15 results on '"Gillies, George T."'
Search Results
2. Contributors
- Author
-
Abrey, Lauren E., primary, Acker, Till, additional, Amundson, Eric, additional, Asadi-Moghaddam, Kaveh, additional, Berens, Michael E., additional, Brem, Henry, additional, Broaddus, William C., additional, Butturini, Anna, additional, Butowski, Nicholas, additional, Carabasi, Matthew, additional, Chamberlain, Marc C., additional, Chang, Susan, additional, Chen, Mike Yue, additional, Chen, Zhi-jian, additional, Chiocca, Antonio E., additional, Demuth, Tim, additional, Doolittle, Nancy D., additional, Dorsi, Michael, additional, Duffner, Patricia K., additional, Kamar, Francois G. El, additional, Engelhard, Herbert H., additional, Fahey, Christopher, additional, Finlay, Jonathan L., additional, Fink, Karen L., additional, Fitzpatrick, Lorna K., additional, Gillies, George T., additional, Guha, Abhijit, additional, Haar, Peter J., additional, Haas-Kogan, Daphne A., additional, Haque, Raqeeb M., additional, Ivanchuk, Stacey M., additional, Jennings, Mark T., additional, Malkin, Mark G., additional, Mikkelsen, Tom, additional, Mohile, Nimish, additional, Mukherjee, Joydeep, additional, Murillo, Tulio P., additional, Nakamura, Jean L., additional, Neuwelt, Edward A., additional, Newton, Herbert B., additional, Paleologos, Nina A., additional, Plate, Karl H., additional, Pollack, Ian F., additional, Pomeroy, Scott L., additional, Raizer, Jeffrey J., additional, Ray-Chaudhury, Abhik, additional, Rempel, Sandra A., additional, Rutka, James T., additional, Scheck, Adrienne C., additional, Steinbach, Joachim P., additional, Teicher, Beverly A., additional, Ullrich, Nicole J., additional, Valyi-Nagy, Tibor, additional, Weathers, Allison L., additional, and Weller, Michael, additional
- Published
- 2006
- Full Text
- View/download PDF
3. [9] Strategies for the design and delivery of antisense oligonucleotides in central nervous system
- Author
-
Broaddus, William C., primary, Prabhu, Sujit S., additional, Wu-Pong, Susanna, additional, Gillies, George T., additional, and Fillmore, Helen, additional
- Published
- 2000
- Full Text
- View/download PDF
4. Risk Factors and Survival Analysis of Spinal Cord Stimulator Explantation.
- Author
-
Dougherty MC, Woodroffe RW, Wilson S, Gillies GT, Howard MA 3rd, and Carnahan RM
- Subjects
- Humans, Retrospective Studies, Risk Factors, Spinal Cord, Survival Analysis, Spinal Cord Stimulation
- Abstract
Objective: The treatment failure rate for spinal cord stimulators (SCS) remains unacceptably high, with reports of removal in up to 30% of patients. The purpose of this study is to perform survival and multivariate regression analyses of patients who have undergone SCS explantation in order to identify patient characteristics that may predict treatment failure., Materials and Methods: We identified 253 patients who underwent SCS placement using current procedural terminology codes in a private health insurance data base spanning 2003-2016. Patient demographics, opioid use, surgical indications, as well as comorbidities were noted. At least 6 months of continuous claims data before and after implantation were required for inclusion. Patients who underwent explantation were defined as those who underwent removal without replacement within 90 days and had at least 90 days of continuous insurance eligibility following removal. Those who underwent removal for infectious reasons were identified with corresponding diagnosis codes., Results: Of the 252 patients who met the inclusion criteria, 17 (6.7%) underwent SCS explantation. Median follow-up time was 2.0 years. Of those who had their system explanted, six patients (2.8%) had their systems removed for infection and 11 (4.3%) for noninfectious reasons. Bivariate analysis revealed that younger age and tobacco use were associated with an increased likelihood of explantation. The Cox proportional hazards analysis demonstrated that younger age, tobacco use, and the presence of "other" mental health disorders were predictive of explantation., Conclusions: In a cohort of SCS patients from multiple institutions, this study demonstrates that explantation for noninfectious reasons is more likely in younger patients, tobacco users, and those with certain psychiatric conditions. With an estimated 10% of patients opting to have their devices removed within 5 years of implantation, refining the ability of clinicians to predict who will see benefit from SCS treatment remains necessary., (© 2020 International Neuromodulation Society.)
- Published
- 2021
- Full Text
- View/download PDF
5. Biomarker Optimization of Spinal Cord Stimulation Therapies.
- Author
-
Nagel SJ, Hsieh J, Machado AG, Frizon LA, Howard MA 3rd, Gillies GT, and Wilson S
- Subjects
- Biomarkers, Humans, Pain Management, Spinal Cord, Chronic Pain therapy, Spinal Cord Stimulation
- Abstract
Objectives: We are in the process of designing and testing an intradural stimulation device that will shorten the distance between the location of the electrode array and the targeted neural tissue, thus improving the efficacy of electrical current delivery. Identifying a biomarker that accurately reflects the response to this intervention is highly valued because of the potential to optimize interventional parameters or predict a response before it is clinically measurable. In this report, we summarize the findings pertaining to the study of biomarkers so that we and others will have an up-to-date reference that critically evaluates the current approaches and select one or several for testing during the development of our device., Materials and Methods: We have conducted a broad survey of the existing literature to catalogue the biomarkers that could be coupled to intradural spinal cord stimulation. We describe in detail some of the most promising biomarkers, existing limitations, and suitability to managing chronic pain., Results: Chronic, intractable pain is an all-encompassing condition that is incurable. Many treatments for managing chronic pain are nonspecific in action and intermittently administered; therefore, patients are particularly susceptible to large fluctuations in pain control over the course of a day. The absence of a reliable biomarker challenges assessment of therapeutic efficacy and contributes to either incomplete and inconsistent pain relief or, alternatively, intolerable side effects. Fluctuations in metabolites or inflammatory markers, signals captured during dynamic imaging, and genomics will likely have a role in governing how a device is modulated., Conclusions: Efforts to identify one or more biomarkers are well underway with some preliminary evidence supporting their efficacy. This has far-reaching implications, including improved outcomes, fewer adverse events, harmonization of treatment and individuals, performance gains, and cost savings. We anticipate that novel biomarkers will be used widely to manage chronic pain., (© 2020 International Neuromodulation Society.)
- Published
- 2021
- Full Text
- View/download PDF
6. Intervertebral Displacement of the Thoracic Spine with and without Loading: Radiographic and in Vitro Measurements.
- Author
-
Seaman SC, Zanaty M, Holland MT, Gillies GT, Howard MA 3rd, and Yamaguchi S
- Subjects
- Humans, Patient Positioning, Retrospective Studies, Risk Assessment, Thoracic Vertebrae surgery, Weight-Bearing, Spinal Cord Stimulation methods, Thoracic Vertebrae diagnostic imaging
- Abstract
Background: We are developing an intradural approach to spinal cord stimulation, where the thin electrode array is affixed stably to the underside of the thoracic spinal dura mater without leakage of cerebrospinal fluid. As part of the design and testing process, we sought to evaluate the potential risk of inadvertent contact of the array with the pial surface of the spinal cord during variations in spinal loading., Methods: As part of the risk assessment process, a 2-part study was undertaken. First, a retrospective review of the imaging studies of 25 patients was done in the supine, 45- and 90-degree positions to measure the positional shift between the T9 and T10 vertebral bodies as a function of spinal angulation. Second, similar measurements were made on a cadaveric model, with and without a prototype intradural stimulator implanted at the T9-T10 position and with and without 13.8 kg (30 lb) of axial spinal loading at the 90-degree orientation., Results: In all cases, the measured relative displacement of the dura mater towards the spinal cord in both the imaging and the cadaveric arms of the study was less than 1 mm., Conclusions: The implantation method for the thin intradural array of the prototype device will ensure that the anatomic separation between it and the pial surface of the spinal cord will be the same as that of the dura mater. Therefore the risk of inadvertent contact will be no greater than that due to the mass effects of standard epidural stimulator implants., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
7. In Vivo Testing of a Prototype Intradural Spinal Cord Stimulator in a Porcine Model.
- Author
-
Holland MT, Seaman SC, Woodroffe RW, Fredericks DC, Kovach CK, Gibson-Corley KN, Gillies GT, and Howard MA 3rd
- Subjects
- Animals, Female, Laminectomy, Swine, Electric Stimulation Therapy methods, Implantable Neurostimulators, Low Back Pain therapy, Spinal Cord surgery
- Abstract
Background: Chronic midline low back pain is the number one reason for disability in the United States despite the prolific use of medical and surgical interventions. Notwithstanding the widespread use of epidural spinal cord stimulators (SCSs), there remains a large portion of the population with inadequate pain control thought to be because of the limited volume of stimulated neural tissue. Intradural SCSs represent an underexplored alternative strategy with the potential to improve selectivity, power efficiency, and efficacy. We studied and carried out development of an intradural form of an SCS. Herein we present the findings of in vivo testing of a prototype intradural SCS in a porcine model., Methods: Six female juvenile pigs underwent surgical investigation. One control animal underwent a laminectomy only, whereas the 5 other animals had implantation of an intradural SCS prototype. One of the prototypes was fully wired to enable acute stimulation and concurrent electromyographic recordings. All animals underwent terminal surgery 3 months postimplantation, with harvesting of the spinal column. Imaging (microcomputed tomography scan) and histopathologic examinations were subsequently performed., Results: All animals survived implantation without evidence of neurologic deficits or infection. Postmortem imaging and histopathologic examination of the spinal column revealed no evidence of spinal cord damage, cerebrospinal fluid fistula formation, abnormal bony overgrowth, or dural defect. Viable dura was present between the intra- and extradural plates of the device. Electromyographic recordings revealed evoked motor units from the stimulator., Conclusions: Chronically implanted intradural device in the porcine model demonstrated safety and feasibility for translation into humans., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
8. Predictors of Reduced Opioid Use With Spinal Cord Stimulation in Patients With Chronic Opioid Use.
- Author
-
Dougherty MC, Woodroffe RW, Wilson S, Gillies GT, Howard MA 3rd, and Carnahan RM
- Subjects
- Adult, Analgesics, Opioid adverse effects, Chronic Pain drug therapy, Female, Humans, Male, Middle Aged, Opioid-Related Disorders diagnosis, Opioid-Related Disorders therapy, Pain Measurement drug effects, Pain Measurement methods, Predictive Value of Tests, Retrospective Studies, Spinal Cord Stimulation methods, Analgesics, Opioid administration & dosage, Chronic Pain diagnosis, Chronic Pain therapy, Insurance Claim Reporting trends, Pain Measurement trends, Spinal Cord Stimulation trends
- Abstract
Objectives: Spinal cord stimulation (SCS) has gained traction as an alternative to chronic opioid therapy in light of the opioid crisis. Prior reports vary widely in their estimates of its effect on opioid consumption. We therefore aimed to address the following questions: 1) Does chronic opioid use change after SCS? 2) Which patient characteristics predict reduced opioid consumption after SCS?, Materials and Methods: Claims from a private health insurance company were used to identify patients with SCS implantation from 2003 to 2014. We required 12 months of continuous data before and after surgery (i.e., a minimum total observation period of two years), and at least two opioid prescription fills in the six months before surgery. Daily morphine equivalent dose (MED) was calculated from prescription medication claims. Diagnosis codes identified common comorbidities., Results: Hundred forty-five patients met inclusion criteria. MED of 65 was the most statistically meaningful preoperative dose threshold. Approximately half of patients decreased opioid use >20% after SCS implantation. Logistic regression analysis revealed age (p = 0.0362), gender (p = 0.0076), and preoperative daily MED < 65 (p = 0.0322) as predictors of meaningful reduction, which was defined as a 20% reduction in MED., Conclusions: With only half of chronic opioid users demonstrating meaningful opioid reduction after SCS implantation, we demonstrate that current SCS technology does not reliably help a larger number of patients reduce opioid usage. Women, older age, and preoperative MED < 65 are predictive of meaningful opioid reduction but only one of these is modifiable. As not all patients saw benefit from their therapies, there is still much room for improvement in the treatment of refractory chronic pain that is associated with failed back surgery syndrome and chronic regional pain syndrome., (© 2019 International Neuromodulation Society.)
- Published
- 2020
- Full Text
- View/download PDF
9. Durotomy Surrogate and Seals for Intradural Spinal Cord Stimulators: Apparatus and Review of Clinical Methods and Materials.
- Author
-
Nagel SJ, Helland L, Woodroffe RW, Frizon LA, Holland MT, Machado AG, Yamaguchi S, Gillies GT, Howard MA 3rd, and Wilson S
- Subjects
- Animals, Electrodes, Implanted, Humans, Neurosurgical Procedures, Postoperative Complications prevention & control, Suture Techniques, Cerebrospinal Fluid Leak etiology, Cerebrospinal Fluid Leak prevention & control, Dura Mater, Spinal Cord Stimulation instrumentation, Spinal Cord Stimulation methods
- Abstract
Introduction: We are developing a novel intradural spinal cord stimulator for treatment of neuropathic pain and spasticity. A key feature is the means by which it seals the dura mater to prevent leakage of cerebrospinal fluid (CSF). We have built and employed a test rig that enables evaluation of candidate seal materials., Methods: To guide the design of the test rig, we reviewed the literature on neurosurgical durotomies. The test rig has a mock durotomy slot with a dural substitute serving as the surrogate dura mater and water as the CSF. The primary experimental goal was to evaluate the effectiveness of candidate gasket materials as seals against CSF leakage in an implanted prototype device, at both normal and super-physiologic pressures. A secondary goal was to measure the transmembrane flows in a representative dural substitute material, to establish its baseline aqueous transport properties., Results: The seals prevented leakage of water at the implantation site over periods of ≈ ten days, long enough for the scar tissue to form in the clinical situation. The seals also held at water pressure transients approaching 250 mm Hg. The residual volumetric flux of water through the dura substitute membrane (Durepair®) was δV
T /A ≈ 0.24 mm3 /min/cm2 , consistent with expectations for transport through the porous membrane prior to closure and equalization of internal/external pressures., Conclusions: We have demonstrated the workability of obtaining robust seal against leakage at the implantation site of a novel intradural stimulator using a custom-designed test rig. Extension of the method to in vivo testing in a large animal model will be the next step., (© 2019 International Neuromodulation Society.)- Published
- 2019
- Full Text
- View/download PDF
10. Contemporary Approaches to Preventing and Treating Infections of Novel Intrathecal Neurostimulation Devices.
- Author
-
Nagel SJ, Frizon L, Maiti T, Machado AG, Gillies GT, Helland L, Woodroffe RW, Howard MA 3rd, and Wilson S
- Subjects
- Central Nervous System Infections therapy, Deep Brain Stimulation, Humans, Practice Guidelines as Topic, Prosthesis-Related Infections therapy, Spinal Cord Stimulation, Surgical Wound Infection therapy, Central Nervous System Infections prevention & control, Implantable Neurostimulators, Neurosurgical Procedures methods, Prosthesis Implantation methods, Prosthesis-Related Infections prevention & control, Surgical Wound Infection prevention & control
- Abstract
Introduction: Contemporary approaches to surgical site infections have evolved significantly over the last several decades in response to the economic pressures of soaring health care costs and increasing patient expectations of safety. Neurosurgeons face multiple unique challenges when striving to avoid as well as manage surgical implant infections. The tissue compartment, organ system, or joint is characterized by biological factors and physical forces that may not be universally relevant. Such implants, once rare, are now routine. Although the prevention, diagnosis, and treatment of surgical site infections involving neural implants has advanced, guidelines are ever changing, and the incidence still exceeds acceptable levels. We assess the impact of these factors on a new class of implantable neuromodulation devices., Methods: The available evidence along with practice patterns were examined and organized to establish relevant groupings for continuing evaluation and to propose justifiable recommendations for the treatment of infections that might arise in the case of intradural spinal cord stimulators., Results: Few studies in the modern era have systematically evaluated preventive behaviors that were applied to intradural neural implants alone. We anticipate that future efforts will focus even more on the investigation of modifiable factors along a continuum from bacterially repellant implants to weight management. Early diagnosis could offer the best hope for device salvage but to date has been largely understudied., Conclusions: Historically, prevention is the cornerstone to infection mitigation. However, immediate diagnosis and hardware salvage have not received the attention deserved, and that approach may be especially important for intradural devices., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
11. Intrathecal Therapeutics: Device Design, Access Methods, and Complication Mitigation.
- Author
-
Nagel SJ, Reddy CG, Frizon LA, Holland MT, Machado AG, Gillies GT, and Howard MA 3rd
- Subjects
- Databases, Factual statistics & numerical data, Humans, Spinal Cord diagnostic imaging, Spinal Cord drug effects, Spinal Cord Injuries diagnostic imaging, Spinal Cord Injuries etiology, Catheterization adverse effects, Catheterization instrumentation, Catheterization methods, Equipment Design, Injections, Spinal adverse effects, Injections, Spinal instrumentation, Injections, Spinal methods, Spinal Cord Injuries therapy
- Abstract
Introduction: The intrathecal space remains underutilized for diagnostic testing, invasive monitoring or as a pipeline for the delivery of neurological therapeutic agents and devices. The latter including drug infusions, implants for electrical modulation, and a means for maintaining the physiologic pressure column. The reasons for this are many but include unfamiliarity with the central nervous system and the historical risks that continue to overshadow the low complication rates in modern clinical series., Materials and Methods: Our intent in this review is to explore the access devices currently on the market, assess the risk associated with breaching the intrathecal space, and propose a research model for bringing to patients the next generation of intrathecal hardware. For this purpose, we reviewed both historical and contemporary literature that pertains to the access devices and catheters intended for both temporary and permanent implantation and the complications thereof., Results: There are few devices that are currently marketed in the United States or Europe for intrathecal use. Most hew to a relatively fixed design pattern predicated on the dimensions and properties of the thecal sac. All are typically composed of soft silicone, and employ a Tuohy needle for access despite design limitations. In general, these catheters are engineered for durability, ease of use, and regional deployment. Devices on the market with steerability or targeted intrathecal fixation are not yet available. Complications, once a legitimate concern, are now quite rare when recommended techniques are followed., Conclusions: Over the next decade, advances in intrathecal catheter design, access techniques, imaging, and greater understanding of the spinal cord neurophysiology will usher in an era where the intrathecal space is recognized as a highly valued diagnostic and therapeutic target. We anticipate that this will occur in several concurrent phases, each with the potential to accelerate the growth of the others., (© 2017 International Neuromodulation Society.)
- Published
- 2018
- Full Text
- View/download PDF
12. Spinal Cord Stimulation for Spasticity: Historical Approaches, Current Status, and Future Directions.
- Author
-
Nagel SJ, Wilson S, Johnson MD, Machado A, Frizon L, Chardon MK, Reddy CG, Gillies GT, and Howard MA 3rd
- Subjects
- Forecasting, Humans, Muscle Spasticity epidemiology, Prospective Studies, Quality of Life, Retrospective Studies, Spinal Cord Injuries epidemiology, Muscle Spasticity physiopathology, Muscle Spasticity therapy, Spinal Cord Injuries physiopathology, Spinal Cord Injuries therapy, Spinal Cord Stimulation methods
- Abstract
Introduction: Millions of people worldwide suffer with spasticity related to irreversible damage to the brain or spinal cord. Typical antecedent events include stroke, traumatic brain injury, and spinal cord injury, although insidious onset is also common. Regardless of the cause, the resulting spasticity leads to years of disability and reduced quality of life. Many treatments are available to manage spasticity; yet each is fraught with drawbacks including incomplete response, high cost, limited duration, dose-limiting side effects, and periodic maintenance. Spinal cord stimulation (SCS), a once promising therapy for spasticity, has largely been relegated to permanent experimental status., Methods: In this review, our goal is to document and critique the history and assess the development of SCS as a treatment of lower limb spasticity. By incorporating recent discoveries with the insights gained from the early pioneers in this field, we intend to lay the groundwork needed to propose testable hypotheses for future studies., Results: SCS has been tested in over 25 different conditions since a potentially beneficial effect was first reported in 1973. However, the lack of a fully formed understanding of the pathophysiology of spasticity, archaic study methodology, and the early technological limitations of implantable hardware limit the validity of many studies. SCS offers a measure of control for spasticity that cannot be duplicated with other interventions., Conclusions: With improved energy-source miniaturization, tailored control algorithms, novel implant design, and a clearer picture of the pathophysiology of spasticity, we are poised to reintroduce and test SCS in this population., (© 2017 International Neuromodulation Society.)
- Published
- 2017
- Full Text
- View/download PDF
13. Comparison of Conventional and Kilohertz Frequency Epidural Stimulation in Patients Undergoing Trialing for Spinal Cord Stimulation: Clinical Considerations.
- Author
-
Reddy CG, Dalm BD, Flouty OE, Gillies GT, Howard MA 3rd, and Brennan TJ
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Pain Management methods, Pain Measurement, Paresthesia diagnosis, Treatment Outcome, Complex Regional Pain Syndromes diagnosis, Complex Regional Pain Syndromes prevention & control, Neuralgia diagnosis, Neuralgia prevention & control, Paresthesia prevention & control, Spinal Cord Stimulation methods
- Abstract
Objective: Compare therapeutic response of patients to conventional versus high-frequency spinal cord stimulation (SCS)., Methods: Twelve patients with back and leg pain who met standard clinical criteria for a trial of conventional SCS (low-frequency stimulation [LFS]) participated in a half-day session of high-frequency stimulation (HFS) during their weeklong conventional trial. HFS consisted of frequencies ranging from 50 Hz to 4 kHz, or 100 Hz to10 kHz, at constant voltage settings increasing from 0.5 V to 10 V. Visual Analog Scale scores from 0 to10 were recorded, along with notes of any clinical discomfort and open patient comments., Results: Two of 12 patients had no benefit from either LFS or HFS. In the remaining 10 patients, paresthesias were significantly altered by HFS, and four experienced complete elimination of paresthesias. Five patients preferred HFS to LFS, with an additional three preferring both equally. Abrupt sensation to the onset of HFS was described in six patients, and in ten patients, HFS allowed maximum voltage stimulation of 10 V without discomfort. The four patients who did not have a successful trial of stimulation had significantly longer duration of pain compared to the eight patients who went on to permanent implant (11.2 vs. 4.3 years, P = 0.04)., Conclusions: HFS significantly altered the feeling of paresthesias in the majority of patients (ten of 12), was preferred to LFS in five of 12 patients, and non-inferior to LFS in eight of 12 patients. Both 4 kHz and 10 kHz stimulation allowed patients to benefit from HFS. HFS allowed maximum voltage stimulation without discomfort., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
14. Kinematic analysis of the gait of adult sheep during treadmill locomotion: Parameter values, allowable total error, and potential for use in evaluating spinal cord injury.
- Author
-
Safayi S, Jeffery ND, Shivapour SK, Zamanighomi M, Zylstra TJ, Bratsch-Prince J, Wilson S, Reddy CG, Fredericks DC, Gillies GT, and Howard MA 3rd
- Subjects
- Animals, Biomechanical Phenomena, Disease Models, Animal, Female, Male, Exercise Test methods, Gait physiology, Sheep physiology, Spinal Cord Injuries diagnosis, Walking physiology
- Abstract
We are developing a novel intradural spinal cord (SC) stimulator designed to improve the treatment of intractable pain and the sequelae of SC injury. In-vivo ovine models of neuropathic pain and moderate SC injury are being implemented for pre-clinical evaluations of this device, to be carried out via gait analysis before and after induction of the relevant condition. We extend previous studies on other quadrupeds to extract the three-dimensional kinematics of the limbs over the gait cycle of sheep walking on a treadmill. Quantitative measures of thoracic and pelvic limb movements were obtained from 17 animals. We calculated the total-error values to define the analytical performance of our motion capture system for these kinematic variables. The post- vs. pre-injury time delay between contralateral thoracic and pelvic-limb steps for normal and SC-injured sheep increased by ~24s over 100 steps. The pelvic limb hoof velocity during swing phase decreased, while range of pelvic hoof elevation and distance between lateral pelvic hoof placements increased after SC injury. The kinematics measures in a single SC-injured sheep can be objectively defined as changed from the corresponding pre-injury values, implying utility of this method to assess new neuromodulation strategies for specific deficits exhibited by an individual., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
15. Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation.
- Author
-
Mahapatra S, Tucker-Schwartz J, Wiggins D, Gillies GT, Mason PK, McDaniel G, Lapar DJ, Stemland C, Sosa E, Ferguson JD, Bunch TJ, Ailawadi G, and Scanavacca M
- Subjects
- Catheter Ablation adverse effects, Electrophysiology, Female, Fourier Analysis, Heart Ventricles injuries, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Statistics as Topic, Sternotomy, Stroke Volume, Time Factors, Ventricular Function, Left, Catheter Ablation methods, Pericardium, Pressure, Tachycardia, Ventricular surgery, Thorax
- Abstract
Background: Nonsurgical subxiphoid pericardial access may be useful in ventricular tachycardia ablation and other electrophysiologic procedures but has a risk of right ventricular puncture., Objective: The purpose of this study was to identify a signature pressure frequency that would help identify the pericardial space and guide access., Methods: The study consisted of 20 patients (8 women and 12 men; mean age 59.1 +/- 14.2 years; left ventricular ejection fraction 25.2% +/- 12.2%; failed 1.8 +/- 0.5 endocardial ablations; unresponsive to 2.0 +/- 1.0 antiarrhythmic drugs; 6 ischemic cardiomyopathy, 12 nonischemic cardiomyopathy, 2 normal heart; 4 previous sternotomy) undergoing epicardial ventricular tachycardia ablation. After pericardial access was obtained, a 10Fr long sheath was used to record pressure inside the pericardium and pleural space. Pressures were analyzed using a fast Fourier transform to identify dominant frequencies in each chamber., Results: Mean pressures in the pleural space and the pericardium were not different (7.7 +/- 1.9 mmHg vs 7.8 +/- 0.9 mmHg, respectively). However, the pericardial space in each patient demonstrated two frequency peaks that correlated with heart rate (1.16 +/- 0.21 Hz) and respiratory rate (0.20 +/- 0.01 Hz), whereas the pleural space in each patient had a single peak correlating with respiratory rate (0.20 +/- 0.01 Hz)., Conclusion: The pericardial space demonstrates a signature pressure frequency that is significantly different from the surrounding space. This difference may make minimally invasive subxiphoid pericardial access safer for nonsurgeons and may have important implications for electrophysiologic procedures., (Copyright 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.